00163UAD8

Amag Pharmaceuticals Inc

Could not find a ticker for this position, may be a filing error

A biopharmaceutical company that grew out of nanoparticle science, AMAG Pharmaceuticals began in 1981 as Advanced Magnetics, Inc., making iron-oxide particles used to brighten MRI scans. It later shifted to therapeutics, selling Feraheme, an intravenous iron treatment for anemia, and Makena, a drug to lower the risk of preterm birth. The company took the AMAG name in 2007 and was folded into Covis Pharma in 2020.

3.25% Convertible Senior Notes due June 1, 2022